To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

European Ultrahigh-Field … - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND)

Journal article
Authors E. Düzel
J. Acosta-Cabronero
D. Berron
G. J. Biessels
Isabella Björkman-Burtscher
M. Bottlaender
R. Bowtell
M. V. Buchem
A. Cardenas-Blanco
F. Boumezbeur
D. Chan
S. Clare
M. Costagli
L. de Rochefort
A. Fillmer
P. Gowland
O. Hansson
J. Hendrikse
O. Kraff
M. E. Ladd
I. Ronen
E. Petersen
J. B. Rowe
H. Siebner
T. Stoecker
S. Straub
M. Tosetti
K. Uludag
A. Vignaud
J. Zwanenburg
O. Speck
Published in Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Volume 11
Pages 538-549
ISSN 2352-8729
Publication year 2019
Published at Institute of Clinical Sciences, Department of Radiology
Pages 538-549
Language en
Keywords Alzheimer's disease (AD), Magnetic resonance imaging (MRI), Mild cognitive impairment (MCI), Parkinson's disease (PD), Subjective cognitive decline (SCD), Ultrahigh-field MRI, Vascular dementia
Subject categories Neurosciences, Neurology


Introduction: The goal of European Ultrahigh-Field Imaging Network in Neurodegenerative Diseases (EUFIND) is to identify opportunities and challenges of 7 Tesla (7T) MRI for clinical and research applications in neurodegeneration. EUFIND comprises 22 European and one US site, including over 50 MRI and dementia experts as well as neuroscientists. Methods: EUFIND combined consensus workshops and data sharing for multisite analysis, focusing on 7 core topics: clinical applications/clinical research, highest resolution anatomy, functional imaging, vascular systems/vascular pathology, iron mapping and neuropathology detection, spectroscopy, and quality assurance. Across these topics, EUFIND considered standard operating procedures, safety, and multivendor harmonization. Results: The clinical and research opportunities and challenges of 7T MRI in each subtopic are set out as a roadmap. Specific MRI sequences for each subtopic were implemented in a pilot study presented in this report. Results show that a large multisite 7T imaging network with highly advanced and harmonized imaging sequences is feasible and may enable future multicentre ultrahigh-field MRI studies and clinical trials. Discussion: The EUFIND network can be a major driver for advancing clinical neuroimaging research using 7T and for identifying use-cases for clinical applications in neurodegeneration. © 2018 The Authors

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?